Sensus Healthcare, Inc. Debt Disclosure

Note 3 — DEBT

In September 2023, the Company entered into a revolving credit facility (the “Credit Facility”) with Comerica Bank (“Comerica”) that originally provided for maximum borrowings of $10 million. In October 2024, the Credit Facility was amended to extend the term of the Credit Facility and to increase the maximum borrowings to $15 million. The Credit Facility may be terminated by the Company or Comerica at any time without penalty. At December 31, 2025, the available borrowings under this facility were $15 million. Any borrowings bear interest at the Secured Overnight Financing Rate plus 2.50% (or 6.37% at December 31, 2025) and would be due upon demand by Comerica. The Credit Facility is secured by all of the Company’s assets. The Credit Facility includes covenants requiring that the Company maintain (1) unencumbered liquid assets having a minimum value of $10.0 million in a Comerica account; (2) minimum profitability of $1 on a trailing 12-month basis; and (3) the contractual relationship with RbM Services, LLC (“RbM”) as the manufacturer of the SRT-100.

At December 31, 2025, the Company was in default under the Credit Facility for failing to maintain the required minimum profitability covenant. The Company was in compliance with its financial covenants under the Credit Facility as of December 31, 2024. There were no borrowings outstanding under the facility at December 31, 2025 and December 31, 2024.

In February 2026, Comerica was acquired by Fifth Third and the Company is currently evaluating any impact this may have on the facility.